Jascha Blobel
CEO, Golden Gait Biotech
Golden Gait Biotech is developing a first-in-class drug for Parkinson’s disease patients that suffer from movement disorders, more specifically Falls and Freezing-of-Gait, 2 unmet medical needs.
Events Jascha Blobel has spoken at
- BioTrinity 2026 14 April 2026 – 15 April 2026